Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.3098
+0.0098 (3.27%)
May 18, 2026, 1:40 PM EST
Avenue Therapeutics Revenue
Avenue Therapeutics had revenue of $1.40M in the twelve months ending March 31, 2026. In the year 2025, Avenue Therapeutics had annual revenue of $1.40M.
Revenue
1.40M
Revenue Growth
n/a
P/S Ratio
0.73
Revenue / Employee
1.40M
Employees
1
Market Cap
1.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.40M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evofem Biosciences | 20.24M |
| Emmaus Life Sciences | 12.03M |
| Lyra Therapeutics | 398.00K |
| Eastgate Biotech | 137.64K |
| Halberd | 6.94K |
Avenue Therapeutics News
- 3 months ago - Avenue Therapeutics enters worldwide license agreement for ATX-04 - TheFly
- 4 months ago - Avenue Therapeutics Transcript: AGM 2025 - Transcripts
- 6 months ago - Avenue Therapeutics announces Baergic Bio acquisition by Axsome - TheFly
- 1 year ago - Biotech Alert: Searches spiking for these stocks today - TheFly
- 1 year ago - Avenue Therapeutics files $35M mixed securities shelf - TheFly
- 1 year ago - Avenue Therapeutics reports Q3 EPS $(1.92) , consensus (94c) - TheFly
- 1 year ago - Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 1 year ago - Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - GlobeNewsWire